A fatal case of bilateral interstitial pneumonia (BLIP): Interferon alpha 2 a induced

Ommurugan Balaji; Kurady Laxminarayana Bairy; Amita Priya D; Joseph Thomas; Navin Patil

doi:10.22159/ajpcr.2017.v10i10.19131

A fatal case of bilateral interstitial pneumonia (BLIP): Interferon alpha 2 a induced

Ommurugan Balaji, Kurady Laxminarayana Bairy, Amita Priya D, Joseph Thomas, Navin Patil

Research output: Contribution to journal › Article

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is a rare lymph proliferative disorder of mature CD4 T-cells caused by the human T-lymph tropic type 1 (HTLV 1) of retrovirus family. Combination of zidovudine and interferon Alfa combination is one of most commonly used regimen. Many drugs are implicated in causing interstitial lung disease. Hence, we report a case of interferon Alfa-induced bilateral interstitial pneumonia in a 32-year-old female patient diagnosed with ATLL with HTLV 1 positivity.

Original language	English
Pages (from-to)	15-16
Number of pages	2
Journal	Asian Journal of Pharmaceutical and Clinical Research
Volume	10
Issue number	10
DOIs	https://doi.org/10.22159/ajpcr.2017.v10i10.19131
Publication status	Published - 01-10-2017

Fingerprint

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmaceutical Science
Pharmacology (medical)

Cite this

Balaji, O., Bairy, K. L., Priya D, A., Thomas, J., & Patil, N. (2017). A fatal case of bilateral interstitial pneumonia (BLIP): Interferon alpha 2 a induced. Asian Journal of Pharmaceutical and Clinical Research, 10(10), 15-16. https://doi.org/10.22159/ajpcr.2017.v10i10.19131

@article{5cc3f291ca7e4d9aa3039dd55c581746,

title = "A fatal case of bilateral interstitial pneumonia (BLIP): Interferon alpha 2 a induced",

abstract = "Adult T-cell leukemia/lymphoma (ATLL) is a rare lymph proliferative disorder of mature CD4 T-cells caused by the human T-lymph tropic type 1 (HTLV 1) of retrovirus family. Combination of zidovudine and interferon Alfa combination is one of most commonly used regimen. Many drugs are implicated in causing interstitial lung disease. Hence, we report a case of interferon Alfa-induced bilateral interstitial pneumonia in a 32-year-old female patient diagnosed with ATLL with HTLV 1 positivity.",

author = "Ommurugan Balaji and Bairy, {Kurady Laxminarayana} and {Priya D}, Amita and Joseph Thomas and Navin Patil",

year = "2017",

month = "10",

day = "1",

doi = "10.22159/ajpcr.2017.v10i10.19131",

language = "English",

volume = "10",

pages = "15--16",

journal = "Asian Journal of Pharmaceutical and Clinical Research",

issn = "0974-2441",

publisher = "Innovare Academics Sciences Pvt. Ltd",

number = "10",

}

TY - JOUR

T1 - A fatal case of bilateral interstitial pneumonia (BLIP)

T2 - Interferon alpha 2 a induced

AU - Balaji, Ommurugan

AU - Bairy, Kurady Laxminarayana

AU - Priya D, Amita

AU - Thomas, Joseph

AU - Patil, Navin

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Adult T-cell leukemia/lymphoma (ATLL) is a rare lymph proliferative disorder of mature CD4 T-cells caused by the human T-lymph tropic type 1 (HTLV 1) of retrovirus family. Combination of zidovudine and interferon Alfa combination is one of most commonly used regimen. Many drugs are implicated in causing interstitial lung disease. Hence, we report a case of interferon Alfa-induced bilateral interstitial pneumonia in a 32-year-old female patient diagnosed with ATLL with HTLV 1 positivity.

AB - Adult T-cell leukemia/lymphoma (ATLL) is a rare lymph proliferative disorder of mature CD4 T-cells caused by the human T-lymph tropic type 1 (HTLV 1) of retrovirus family. Combination of zidovudine and interferon Alfa combination is one of most commonly used regimen. Many drugs are implicated in causing interstitial lung disease. Hence, we report a case of interferon Alfa-induced bilateral interstitial pneumonia in a 32-year-old female patient diagnosed with ATLL with HTLV 1 positivity.

UR - http://www.scopus.com/inward/record.url?scp=85030537948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030537948&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i10.19131

DO - 10.22159/ajpcr.2017.v10i10.19131

M3 - Article

AN - SCOPUS:85030537948

VL - 10

SP - 15

EP - 16

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 10

ER -

Access to Document

10.22159/ajpcr.2017.v10i10.19131